NEW POTENTIAL OF MEXICOR IN THE TREATMENT OF CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME

NEW POTENTIAL OF MEXICOR IN THE TREATMENT OF CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME

The study included 60 patients, aged 45-65 years, with metabolic syndrome (MS), Functional Class II-III chronic heart failure (CHF), and recent myocardial infarction (MI). The participants were randomised into 2 groups (n=30 in each). The main group received standard CHF therapy and Mexicor (0,4 g/d...

Full description

Bibliographic Details
Main Authors: M. E. Statsenko, E. D. Evtereva, S. V. Turkina, S. V. Fabritskaya, O. E. Sporova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2010-12-01
Series:Российский кардиологический журнал
Subjects:
metabolic syndrome
chronic heart failure
mexicor
left ventricular remodeling
diastolic function
insulin resistance
carbohydrate and lipid metabolism
chronic inflammation syndrome
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1511

Internet

https://russjcardiol.elpub.ru/jour/article/view/1511

Similar Items